Outstanding days at #EHRA2025 !
I would like to thank the #CCB team for the opportunity to be part of this congress and for the amazing experience at CCB Frankfurt und Main-Taunus
#EHRA2025#EP#EHRA#CCB
In the SEQUOIA-HCM trial, researchers evaluated the efficacy and safety of aficamten in adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). Read the full trial results and Plain Language Summary: https://t.co/8M0wEtJ96d